UnitedHealth Group Incorporated (NYSE:UNH) announced its quarterly earnings data on Tuesday. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09, Bloomberg Earnings reports. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.17 earnings per share. UnitedHealth Group updated its FY17 guidance to $10.00 EPS.
UnitedHealth Group (UNH) opened at 203.89 on Wednesday. UnitedHealth Group has a 52-week low of $133.03 and a 52-week high of $206.62. The firm has a market cap of $197.13 billion, a P/E ratio of 24.49 and a beta of 0.63. The company’s 50 day moving average is $196.56 and its 200 day moving average is $184.87.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.
A number of equities research analysts have recently weighed in on UNH shares. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, June 28th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Deutsche Bank AG boosted their price objective on shares of UnitedHealth Group from $187.00 to $197.00 and gave the company a “buy” rating in a report on Thursday, July 13th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $209.56.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 76,174 shares of company stock valued at $14,981,909. 0.89% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in UNH. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after acquiring an additional 603 shares during the last quarter. Blue Chip Partners Inc. acquired a new position in UnitedHealth Group during the second quarter worth about $110,000. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 150 shares during the last quarter. Bruderman Asset Management LLC acquired a new position in UnitedHealth Group during the second quarter worth about $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. Institutional investors own 86.11% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.